Talphera (TLPH) Liabilities from Discontinued Operations (2022 - 2026)

Talphera's (TLPH) quarterly Liabilities from Discontinued Operations came in at 650000.0 in Q1 2026, little changed year-on-year from 650000.0 in Q1 2025, and little changed quarter-over-quarter from 650000.0 in Q4 2025.

Talphera (TLPH) Liabilities from Discontinued Operations (2022 - 2026) Analysis & Trends

Talphera's Liabilities from Discontinued Operations history runs 5 years deep, the most recent figure standing at 650000.0 for Q1 2026.

  • On a quarterly basis, Liabilities from Discontinued Operations changed 0.0% year-over-year to 650000.0 in Q1 2026; TTM through Mar 2026 was 650000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at 650000.0, down 10.1% from the prior year.
  • Liabilities from Discontinued Operations was little changed at 650000.0 in Q1 2026 per TLPH's latest filing, from 650000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 4620000.0 in Q4 2022 and bottomed at 650000.0 in Q1 2025.
  • The 5-year median for Liabilities from Discontinued Operations is 723000.0 (2024), against an average of 1225615.38.
  • Across the five-year window, Liabilities from Discontinued Operations plunged 84.18% in 2023 and changed 0.0% in 2026, its largest moves.
  • Year by year, Liabilities from Discontinued Operations stood at 4620000.0 in 2022, then plunged by 84.18% to 731000.0 in 2023, then dropped by 1.09% to 723000.0 in 2024, then declined by 10.1% to 650000.0 in 2025, then changed by 0.0% to 650000.0 in 2026.
  • Per Business Quant, the three latest TLPH Liabilities from Discontinued Operations figures stand at 650000.0 (Q1 2026), 650000.0 (Q4 2025), and 650000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Talphera 47.31 Mn 9.48 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 650,000.00
Mar 31, 2026 650,000.00
Dec 31, 2025 650,000.00
Dec 31, 2025 650,000.00
Sep 30, 2025 650,000.00
Sep 30, 2025 650,000.00
Jun 30, 2025 650,000.00
Jun 30, 2025 650,000.00
Mar 31, 2025 650,000.00
Mar 31, 2025 650,000.00
Dec 31, 2024 723,000.00
Dec 31, 2024 723,000.00
Sep 30, 2024 723,000.00
Sep 30, 2024 723,000.00
Jun 30, 2024 723,000.00
Jun 30, 2024 723,000.00
Mar 31, 2024 730,000.00
Mar 31, 2024 730,000.00
Dec 31, 2023 731,000.00
Dec 31, 2023 731,000.00